Radionuclide Therapy A multiple-choice quiz consists of: 10 QuestionsQuestions are selected randomly from a collection of 17 questions. More Questions You will get deferent questions every time you take the quiz. Correct AnswersThere could be more than one correct answer, select all that apply.Skip QuestionsYou are allowed to scroll backward and forward before submitting your answers.10 MinutesThe quiz has a time limit. Time's up You can still submit your answers after the allowed period of time has ended . When ready, click Next to start the quiz. Name (Required) Email (Optional) Twitter (Optional) 1. To reduce radiation exposure to the patient undergoing radioactive iodine (RAI) treatment, all of the following recommendations will be helpful EXCEPT: Patient should use antiperspirant medications Patient should urinate frequently Patient should be well hydrated Patient laxatives 2. A lone “cold” nodule in an otherwise normal thyroid gland warrants: Surgical removal. Radiation therapy. Chemotherapy. Fine needle aspiration biopsy. 3. According to the Society of Nuclear Medicine “SNM Procedure Guideline for Therapy of Thyroid Disease with I-131 (Sodium Iodide),” typically administered activity for treatment of presumed thyroid cancer in the neck or mediastinal lymph nodes is in the range: 100–150 mCi. 200–250 mCi. 50–100 mCi. 150–200 mCi. 4. The hematologic toxicity of Y-90 Zevalin therapy is common. All of the following can be a sign of hematologic toxicity EXCEPT: Fever Arrhythmia Anemia Bruising 5. An ultimate treatment for patients who are nonresponsive to or cannot tolerate other available therapies for a particular illness and whose prognosis is often poor is called: Standard therapy. Retreatment. Salvage therapy. Consolidation therapy. 6. What is the predominant toxicity of radioisotopes used in the treatment of bone metastases? Leukemia Myelosuppression Gastritis Radiation pneumonitis 7. Samarium-153 (Quadramet) is a therapeutic radiopharmaceutical used to treat: Polycythemia vera Dyspnea in lung Ca Pain in bony metastases Medullary thyroid carcinoma 8. The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT: Performing pulmonary function tests Blocking thyroid uptake of free radioiodine A diagnostic MIBG scan or previous posttreatment I-131 MIBG scan Reviewing potential interfering medications 9. Which of the following radioisotopes approved used in the treatment of bone metastases has a significant gamma emission and can be used both for imaging and therapy? Sm-153 P-32 Sr-89 Ra-223 10. The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT: Reviewing potential interfering medications A diagnostic MIBG scan or previous posttreatment I-131 MIBG scan Blocking thyroid uptake of free radioiodine Performing pulmonary function tests 1 out of 10 Time's upTime is Up! بواسطة ناصر المطيري|2021-03-30T09:35:30+03:00مارس 30th, 2021|لا توجد تعليقات شارك هذه الصفحة, واترك رأيك حول الموضوع باستخدام وسيلة التواصل التي تناسبك FacebookXLinkedInWhatsAppPinterestEmail عن: ناصر المطيري كبير أخصائيي الطب النووي في مستشفى حفر الباطن المركزي و مؤسس موقع نيوكليرمد. اترك تعليقاًCancel reply
اترك تعليقاً